Cancer News and Research

Latest Cancer News and Research

HPV vaccine shows success in young Australian women, study says

"A vaccine to prevent cervical cancer, triggered by the human papillomavirus (HPV), has helped reduce the number of teenage girls developing abnormalities in their cervix by as much as 50 percent in a study in Australia," according to a report published Friday in the Lancet, Reuters reports.

18 Jun 2011

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Controversy over the F.D.A.'s proposal to withdraw approval of Avastin for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds.

18 Jun 2011

Low levels of education, poverty and other social factors contribute to many U.S. deaths

How researchers classify and quantify causes of death across a population has evolved in recent decades. In addition to long-recognized physiological causes such as heart attack and cancer, the role of behavioral factors-including smoking, dietary patterns and inactivity-began to be quantified in the 1990s. More recent research has begun to look at the contribution of social factors to U.S. mortality.

18 Jun 2011

Pancreatic Cancer Action Network calls on federal government to make research a national priority

The Pancreatic Cancer Action Network is calling on the federal government to make pancreatic cancer research a national priority, as the incidence and death rates for the fourth leading cause of cancer death in our country continue to increase according to "Cancer Facts & Figures 2011," a report released today by the American Cancer Society.

18 Jun 2011

PDA urges public to undergo screening for oral cancer

Oral cancer claims more lives than leukemia, Hodgkin's lymphoma, laryngeal cancer, testicular cancer, thyroid cancer, or skin cancer. In 2010, approximately 36,540 Americans were diagnosed with this largely preventable type of cancer that affects the mouth and throat; 7,880 died of the disease. Early detection is essential to dramatically reduce the number of deaths from oral cancer.

18 Jun 2011

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer.

18 Jun 2011

CRMH hosts educational conference to close the gap in health disparities

Health care reform, environmental disasters and access to care are just a few of the topics offered at the 9th Annual Disparities in Health in the Global Context Summer Workshop.

18 Jun 2011

News highlights: Report urges smoke-free laws; N.J. state workers rally against pension and health care changes

A million people would quit smoking, nearly 400,000 teenagers would never start, and more than 700,000 lives would be saved if the 27 U.S. states that don't have good antismoking laws would adopt them, the American Cancer Society projected on Wednesday.

18 Jun 2011

OptumHealth names Women & Infants as Center of Excellence for Reproductive Resource Services

Women & Infants Hospital of Rhode Island has been named a Center of Excellence for Reproductive Resource Services by OptumHealth, an independent audit company.

18 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Niclosamide drug effective against colon cancer metastasis

A compound that for about 60 years has been used as a drug against tapeworm infection is also apparently effective against colon cancer metastasis, as studies using mice have now shown.

18 Jun 2011

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.

18 Jun 2011

Tobacco promotion banned in Queensland stores

Queensland stores are directed to refrain from openly displaying cigarettes and other tobacco products. Under laws introduced on Thursday, all retail advertising and promotion of tobacco and other smoking-related products will be banned.

17 Jun 2011

Adolescent obese males at risk of cancer later in life: Study

According to a new study, men who are obese as teenagers are at a greater risk of cancer. Researchers claim that the risk remains even among those who lose weight later in life.

17 Jun 2011

Cancer vaccine shows promise

In the latest research news, a cervical cancer vaccine programme has produced the first evidence of disease prevention among treated women. This vaccine targets human papillomavirus (HPV), the virus believed to trigger cervical cancer in women.

17 Jun 2011

RHEI receives Chinese SFDA acceptance letter for MuGard

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, RHEI Pharmaceuticals has received the acceptance letter from the State Food and Drug Administration (SFDA) of China acknowledging all necessary documentation for the MuGard has been submitted and accepted.

17 Jun 2011

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

17 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Structural biologists at Cold Spring Harbor Laboratory (CSHL) have obtained a precise molecular map of the binding site for an allosteric inhibitor in a subtype of the NMDA (N-methyl-D-aspartate) receptor, which is commonly expressed in brain cells.

17 Jun 2011

Cancer News and Research

Latest Cancer News and Research

HPV vaccine shows success in young Australian women, study says

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Low levels of education, poverty and other social factors contribute to many U.S. deaths

Pancreatic Cancer Action Network calls on federal government to make research a national priority

PDA urges public to undergo screening for oral cancer

Scientists create first roadmap to understand estrogen signaling in breast cancer cells

CRMH hosts educational conference to close the gap in health disparities

News highlights: Report urges smoke-free laws; N.J. state workers rally against pension and health care changes

OptumHealth names Women & Infants as Center of Excellence for Reproductive Resource Services

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Niclosamide drug effective against colon cancer metastasis

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Tobacco promotion banned in Queensland stores

Adolescent obese males at risk of cancer later in life: Study

Cancer vaccine shows promise

RHEI receives Chinese SFDA acceptance letter for MuGard

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

NASDAQ halts Regeneron's common stock

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in